Didn't find the company you were looking for? Our full system contains all Danish companies, including comprehensive credit risk reports. Register here to get started.
You can find text and video tutorials here that explain how to use our system.
Tetra Pharm Technologies ApS
CVR number: 40738223
Søndre Jernbanevej 11, 3400 Hillerød
contact@tetrapharm.eu
Income statement (kDKK)
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 |
| Net sales | |||
| Gross profit | - 926.10 | 3 208.29 | - 510.30 |
| Employee benefit expenses | - 146.33 | -3 534.92 | -10 324.45 |
| Total depreciation | -72.52 | -87.60 | -98.52 |
| EBIT | -1 144.96 | - 414.24 | -10 933.27 |
| Other financial expenses | -6.11 | -87.64 | -58.43 |
| Pre-tax profit | -1 151.07 | - 501.87 | -10 991.70 |
| Income taxes | 253.22 | 807.47 | 3 224.01 |
| Net earnings | - 897.85 | 305.59 | -7 767.69 |
Assets (kDKK)
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Development expenditure | 3 168.39 | 8 129.68 | |
| Intangible assets total | 3 168.39 | 8 129.68 | |
| Buildings | 221.01 | 580.01 | 3 112.70 |
| Machinery and equipment | 116.71 | 138.96 | 560.62 |
| Tangible assets total | 337.72 | 718.97 | 3 673.32 |
| Other receivables | 138.00 | 922.31 | 1 000.78 |
| Investments total | 138.00 | 922.31 | 1 000.78 |
| Non-current other receivables | 3 859.28 | ||
| Long term receivables total | 3 859.28 | ||
| Semifinished products | 3 048.97 | 6 060.75 | |
| Inventories total | 3 048.97 | 6 060.75 | |
| Prepayments and accrued income | 63.83 | 3.48 | |
| Current other receivables | 119.37 | 311.22 | 1 263.13 |
| Current deferred tax assets | 253.22 | 1 060.69 | 4 284.70 |
| Short term receivables total | 436.42 | 1 371.90 | 5 551.31 |
| Cash and bank deposits | 5 198.40 | 60 916.49 | |
| Cash and cash equivalents | 5 198.40 | 60 916.49 | |
| Balance sheet total (assets) | 912.14 | 18 288.23 | 85 332.33 |
Equity and liabilities (kDKK)
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Share capital | 40.00 | 48.08 | 62.39 |
| Share premium account | 1.65 | 15 027.86 | 90 009.59 |
| Other reserves | 2 471.36 | 6 341.15 | |
| Retained earnings | -4 066.24 | -8 721.93 | |
| Profit of the financial year | - 897.85 | 305.59 | -7 767.69 |
| Shareholders equity total | - 856.20 | 13 786.65 | 79 923.51 |
| Provisions | 697.03 | 1 788.53 | |
| Non-current trade creditors | 28.26 | 194.89 | 420.84 |
| Non-current owed to group member | 2 637.63 | 2 331.78 | |
| Non-current other liabilities | 1 356.80 | ||
| Non-current deferred tax liabilities | 972.04 | ||
| Non-current liabilities total | 1 385.06 | 3 804.55 | 2 752.62 |
| Current loans from credit institutions | 383.27 | ||
| Current owed to participating | 1 321.12 | ||
| Other non-interest bearing current liabilities | -1 321.12 | 867.67 | |
| Current liabilities total | 383.27 | 867.67 | |
| Balance sheet total (liabilities) | 912.14 | 18 288.23 | 85 332.33 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
... and more!
No registration needed.